CDEK by Data4ThePeople

Sign in Sign up

← All organizations

NeuroTau, Inc.

For profit

Also known as: NeuroTau, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Jan 1, 2021

Timeline

2010s

Nov 6, 2017
NeuroTau, Inc.— Founded

Drugs by trial phase (1 distinct, 1 trials)

Phase 2 (1 own, 0 via acquisition)

tolfenamic acid

Indications

Studied for

Supranuclear Palsy, Progressive

Recent trials (2)

NCT04253132Lead sponsorPhase 1/Phase 2Jan 1, 2021
NCT04253132Study directorPhase 1/Phase 2Jan 1, 2021

Details

Founded: Warwick, RI, US Nov 6, 2017
Last known activity: Jan 1, 2021